ATE147406T1 - Synthetisches cdw52(campath-1) peptidantigen - Google Patents
Synthetisches cdw52(campath-1) peptidantigenInfo
- Publication number
- ATE147406T1 ATE147406T1 AT92908299T AT92908299T ATE147406T1 AT E147406 T1 ATE147406 T1 AT E147406T1 AT 92908299 T AT92908299 T AT 92908299T AT 92908299 T AT92908299 T AT 92908299T AT E147406 T1 ATE147406 T1 AT E147406T1
- Authority
- AT
- Austria
- Prior art keywords
- ser
- ala
- asn
- pct
- synthetic
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 102100024217 CAMPATH-1 antigen Human genes 0.000 title abstract 2
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 125000000773 L-serino group Chemical group [H]OC(=O)[C@@]([H])(N([H])*)C([H])([H])O[H] 0.000 abstract 1
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical group OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 abstract 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical group OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919108056A GB9108056D0 (en) | 1991-04-16 | 1991-04-16 | Synthetic antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE147406T1 true ATE147406T1 (de) | 1997-01-15 |
Family
ID=10693343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92908299T ATE147406T1 (de) | 1991-04-16 | 1992-04-16 | Synthetisches cdw52(campath-1) peptidantigen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5494999A (de) |
| EP (1) | EP0580672B1 (de) |
| JP (1) | JP3329811B2 (de) |
| AT (1) | ATE147406T1 (de) |
| DE (1) | DE69216600T2 (de) |
| DK (1) | DK0580672T3 (de) |
| ES (1) | ES2100340T3 (de) |
| GB (1) | GB9108056D0 (de) |
| GR (1) | GR3023063T3 (de) |
| WO (1) | WO1992018530A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4002981C2 (de) * | 1990-02-01 | 1998-03-12 | Ihf Inst Fuer Hormon Und Fortp | Humane, Epididymis-spezifische Polypeptide und deren Verwendung zur Therapie und Diagnose männlicher Infertilität |
| GB9215071D0 (en) * | 1992-07-15 | 1992-08-26 | Wellcome Found | Recombinant antigen |
| US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| US6225444B1 (en) | 1998-02-10 | 2001-05-01 | Protarga, Inc. | Neuroprotective peptides and uses thereof |
| US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
| JP4634694B2 (ja) * | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
| JP2005500988A (ja) | 2001-03-23 | 2005-01-13 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪族アミン薬物複合体 |
| JP3977162B2 (ja) * | 2002-06-21 | 2007-09-19 | 株式会社バンダイナムコゲームス | キャラクタ情報管理装置、プログラム及び情報記憶媒体 |
| AU2015207936A1 (en) * | 2009-05-13 | 2015-08-27 | Genzyme Corporation | Anti-human CD52 immunoglobulins |
| NZ621170A (en) | 2009-05-13 | 2015-08-28 | Genzyme Corp | Anti-human cd52 immunoglobulins |
| AR095199A1 (es) | 2013-03-15 | 2015-09-30 | Genzyme Corp | Anticuerpos anti-cd52 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68909441T2 (de) * | 1988-02-12 | 1994-02-10 | British Tech Group | Modifizierte Antikörper. |
-
1991
- 1991-04-16 GB GB919108056A patent/GB9108056D0/en active Pending
-
1992
- 1992-04-16 US US08/137,016 patent/US5494999A/en not_active Expired - Lifetime
- 1992-04-16 DE DE69216600T patent/DE69216600T2/de not_active Expired - Lifetime
- 1992-04-16 ES ES92908299T patent/ES2100340T3/es not_active Expired - Lifetime
- 1992-04-16 DK DK92908299.8T patent/DK0580672T3/da active
- 1992-04-16 AT AT92908299T patent/ATE147406T1/de active
- 1992-04-16 EP EP92908299A patent/EP0580672B1/de not_active Expired - Lifetime
- 1992-04-16 JP JP50775292A patent/JP3329811B2/ja not_active Expired - Lifetime
- 1992-04-16 WO PCT/GB1992/000705 patent/WO1992018530A1/en not_active Ceased
-
1997
- 1997-04-08 GR GR970400731T patent/GR3023063T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9108056D0 (en) | 1991-06-05 |
| ES2100340T3 (es) | 1997-06-16 |
| GR3023063T3 (en) | 1997-07-30 |
| JP3329811B2 (ja) | 2002-09-30 |
| US5494999A (en) | 1996-02-27 |
| DE69216600T2 (de) | 1997-07-03 |
| WO1992018530A1 (en) | 1992-10-29 |
| EP0580672A1 (de) | 1994-02-02 |
| EP0580672B1 (de) | 1997-01-08 |
| DK0580672T3 (da) | 1997-07-07 |
| JPH06510521A (ja) | 1994-11-24 |
| DE69216600D1 (de) | 1997-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
| DE69534872D1 (de) | Gereinigte primate clta-8 antigene und verwandte reagenzien | |
| DE69222956D1 (de) | Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers | |
| DE69227041D1 (de) | Expression und reinigung von rekombinantem, löslichem gewebefaktor | |
| DK0580672T3 (da) | Syntetisk CDw52-(CAMPATH-1)-peptidantigen | |
| ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
| EP0253325A3 (de) | Von Onkogenen abgeleitete Peptide | |
| AU612683B2 (en) | Synthetic peptides, antibodies directed against them, and the use thereof | |
| FI925321A0 (fi) | Immunodiagnostiskt ledinflammationstest | |
| PT635025E (pt) | Processo para preparar proteinas modificadas | |
| DK329789A (da) | Monoklonalt antistof | |
| DE59611293D1 (de) | Protein mit dnase-aktivität | |
| ATE33842T1 (de) | Immuninterferon und verfahren zu seiner reinigung. | |
| PT650523E (pt) | Antigene cdw52 recombinante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |